FDA Inspection 1282698 — Actavis Laboratories UT, Inc.

Actavis Laboratories UT, Inc. — FEI 1000117147

The FDA completed an inspection of Actavis Laboratories UT, Inc. on Sep 19, 2025 in Salt Lake City, UT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 19, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Salt Lake City, UT (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
145021 CFR 211.113(a)Procedures for non-sterile drug products
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
440221 CFR 211.192Written record of investigation incomplete

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.